by Plus Therapeutics | Jun 10, 2025 | GBM
At Plus Therapeutics, advancing treatment for patients with recurrent glioblastoma (GBM) requires collaboration with some of the brightest minds in brain cancer research and neurosurgery. Today, we’re proud to feature one of our esteemed RESPECT-GBM Principal...
by Plus Therapeutics | Jun 10, 2025 | GBM
Spotlight on Dr. Toral Patel: Leading Brain Tumor Surgeon and Principal Investigator in the ReSPECT-GBM Clinical Trial As part of our ongoing commitment to highlight the incredible medical professionals behind the ReSPECT-GBM clinical trial, today we are proud to...
by Plus Therapeutics | Jun 8, 2025 | GBM
Each year, Brain Tumor Awareness Day serves as a critical reminder of the challenges faced by brain cancer patients, and the urgent need for continued research, innovation, and advocacy. At Plus Therapeutics, we are proud to stand alongside passionate individuals and...
by Plus Therapeutics | Jun 8, 2025 | GBM
Honoring Brain Tumor Awareness Day: Supporting Glioblastoma Patients Through Advocacy and Innovation Today is Brain Tumor Awareness Day—a day dedicated to raising awareness for those affected by brain tumors and honoring the patients, caregivers, and advocates working...
by Plus Therapeutics | Jun 5, 2025 | LM
June Is Brain and Spine Metastasis Awareness Month: Spotlight on Leptomeningeal Metastases and New Treatment Approaches Following Brain Cancer Awareness Month, June marks Brain and Spine Metastasis Awareness Month, a critical time to raise awareness about the...
Recent Comments